DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Bean J, Brennan C, Shih JY. et al.
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.
Proc Natl Acad Sci U S A 2007;
104 (52) 20932-20937
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.